Features

Feature

Disagreement and conflict in teams

This episode of The PJ Pod explores common causes of conflict in the pharmacy workplace and outlines how staff members and managers can avoid or resolve conflict scenarios.…

Published: 20 February 2025

Feature

Allergic rhinitis: diagnosis and treatment

Allergic rhinitis can have a significant impact on quality of life, as well as performance in school and at work. In most cases, symptoms can be treated with a variety of products available from community pharmacies.…

Published: 19 February 2025

Supported content

Feature

The dangers of propranolol for anxiety

Despite warnings issued five years ago about the risks of prescribing propranolol to treat anxiety, experts say there is still not enough being done to protect patients.…

Published: 12 February 2025

Feature

The novel schizophrenia drug showing renewed potential for better outcomes

A novel acetylcholine receptor drug has become the first new medicine to treat schizophrenia in decades. But even after gaining approval in the United States, experts are still conflicted on its benefits over current antipsychotic medicines.…

Published: 5 February 2025

Feature

Spotlight: Palliative care access

In this ‘Spotlight’ episode of The PJ Pod, we consider the current state of palliative care and how it could be improved to ensure equitable access.…

Published: 29 January 2025

Feature

What does the assisted dying legislation mean for pharmacy?

The Terminally Ill Adults (End of Life) Bill still has a long way to go before becoming law and pharmacy organisations have unresolved questions about what it might mean for pharmacy practice.…

Published: 22 January 2025

Feature

A shrinking world: What the COVID-19 pandemic taught us about travel vaccines in a globalised society

This is a non-promotional article fully developed and funded by Sanofi, and intended for healthcare professionals in the UK and Ireland only.…

Published: 20 January 2025

Engineering precision: developing the next generation of antibody drug conjugates

Researchers are working to create a new generation of these targeted cancer therapies to improve efficacy and minimise off-target adverse effects.…

Published: 15 January 2025

Feature

BRUKINSA is now reimbursed across the UK for R/R MZL

Read more to learn how BRUKINSA could benefit your patients with R/R MZL.…

Published: 13 January 2025

Promotional content

Feature

‘A wicked problem’: tackling variable access to urgent palliative care medicines

Despite national incentives and locally commissioned services designed to improve availability of critical end-of-life drugs from community pharmacies, access to urgent palliative care medicines remains a challenge.…

Published: 8 January 2025